Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
Assa Abloy BMay 28, 2024
AstraZenecaMay 28, 2024
SinchMay 28, 2024
Hexatronic GroupMay 28, 2024
AxfoodMay 28, 2024

The market showed a small loss Tuesday, and OMX Stockholm PI ended the day at 995 points, which is a decline of 0.4 percent.

490 shares showed a gain and 470 showed a loss. 74 shares were unchanged and closed at the same price as the previous day. There was no trading in 48 shares.

Total value of the trading volume for shares and primary capital certificates Tuesday was approximately 148.8 billion.

Calliditas Therapeutics was up 78.2 percent to close at 202 kronor. The stock thereby broke the previous record from Nov 2020 and set a new all time high. It was also very high volume. Overall it was traded for 1592 millions kronor in the stock, which is 30 times as much as normal daily turnover. The stock is trend wise positive in the medium term and has support at 132 kronor.
SAAB B developed negatively and fell 1.3 percent to a close of 248 kronor. The stock thereby reversed down after ten days of gains. It does, however, look good technically. The stock is trend wise positive in the medium term, has broken up through resistance at 240 kronor and a further increase is indicated.
Precise Biometrics gained 7.1 percent to 3.00 kronor. The stock has by that gained 140.0 percent since the buy signal from the double bottom formation two months ago.
Cell Impact ended with a solid gain of 29.6 percent and closed at 0.32 kronor. We must go back to Dec 8. 2023 to find an equally strong rise. That time the stock gained 60.3 percent. The stock has now risen for the sixth day in a row and this past week the stock has gained as much as 79.8 percent. It was also high volume. Overall it was traded for 11 millions kronor in the stock, which is six times as much as normal daily turnover. The stock is trend wise negative in the medium term.
AstraZeneca closed at 1621 kronor after posting a loss of 2.4 percent. The previous time the stock lost this much was Feb 12, when it closed down 2.9 percent. The stock triggered a sell signal by the break down through the support at 1643 kronor in double top formation. A further drop to 1598 kronor within three weeks is indicated.

US 500 approximately even on Tuesday
S&P 500 moved more or less horizontally on Tuesday and closed at 5306 points (+0.0 percent). The index has thereby closed up 13 out of the past 18 days.

Indices
OMX Stockholm PI
arrow green   Positive Candidate
Investors have paid higher prices over time to buy OMX Stockholm PI and the index is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The price has risen strongly since the positive signal from the rectangle formation at the break through resistance at 828. The objective at 914 is now met, but the formation still gives a signal in the same direction. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 860 points. RSI is above 70 after a good price increase the past weeks. The index has strong positive momentum and further increase is indicated. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the medium long term.
S&P 500
arrow green   Positive Candidate
S&P 500 shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The index has broken up through resistance at points 5250. This predicts a further rise. The index is assessed as technically positive for the medium long term.
Today's candidate
Metacon (META) Price 0.80, May 28, 2024
chart
Metacon has broken the falling trend channel in the medium long term and reacted strongly up. For the time being, it is difficult to say anything about the future trend direction. The stock has broken up through resistance at kronor 0.68. This predicts a further rise. In case of negative reactions, there will now be support at kronor 0.68. Positive volume balance strengthens the stock in the short term. RSI above 70 shows that the stock has strong positive momentum in the short term. Investors have steadily paid more to buy the stock, which indicates increasing optimism and that the price will continue to rise. The stock is overall assessed as technically positive for the medium long term.
Recommendation: Positive
Latest days indices
AEX-0.42%912.23
CAC40-0.92%8057.80
COMPX0.59%17020.00
DAX-0.52%18678
HEX-0.24%10339.00
N100-0.53%1545.59
OMXC25GI-0.17%2301.15
OMXSPI-0.44%995.46
OSEBX-0.03%1433.82
PSI20-0.40%6910.19
TECDAX-0.84%3410.83
BUK100P-0.77%824.14
EURUSD0.10%1.0900
CL (OIL)2.71%79.83
Indices Evaluations
 SML
AEXposneutralpos
CAC40negpospos
COMPXpospospos
DAXpospospos
HEXneutralneutralneg
N100pospospos
OMXC25GIpospospos
OMXSPIpospospos
OSEBXpospospos
PSI20neutralpospos
TECDAXneutralneutralpos
BUK100Ppospospos
EURUSDposneutralneutral
CL (OIL)neutralneutralneutral

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
Stockholmsbörsen - Medium term
 
      
38% 45% 17%
 426 Buy Candidates
 500 Neutral
 197 Sell Candidates
Track what the insiders are doing! Insider buys in green, insider sales in red.
 
   Last month:
   80% Positive
   640 Positive
   165 Negative
Disclaimer Copyright © 2024 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Cancel Analysis News
[ Back to default newsletter setup ]

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

×

Please login here

 
Forgot your password?

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.

Our use of cookies

When you use our website, we store a cookie on your device. The cookie is used to recognize your device so that your settings work when you use our websites. The information that is stored is completely anonymised. Cookies are automatically deleted after a certain time.

Necessary cookies

Investtech uses cookies to ensure basic functions such as page navigation and language selection. Without such cookies, the website does not function as it should. You cannot therefore make a reservation against these. If you still want to disable such cookies you can do so in your browser settings. In the Cookies section add this website to the list of sites which are not allowed to save cookies on your device.

Cookies from Google

We use services from Google Analytics and Google AdWords. These register cookies on your device when you visit our website. Google registers your IP address in order to keep statistics on user activity on the website. The IP address is anonymised, so that we have no opportunity to link the activities to a specific person. We use these statistics to be able to offer more interesting content on the website and to constantly improve ourselves. Google AdWords collects data so that our advertising on other websites gives better results. We cannot trace the data of individuals.

Allow cookies from Google